Strongbridge Biopharma Plc Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Strongbridge Biopharma are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Strongbridge Biopharma Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Strongbridge Biopharma is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Quick Ratio | 2.88 | |
| Fifty Two Week Low | 1.8500 | |
| Target High Price | 8.00 | |
| Fifty Two Week High | 4.2600 | |
| Target Low Price | 3.25 |
Strongbridge |
Strongbridge Biopharma Relative Risk vs. Return Landscape
If you would invest (100.00) in Strongbridge Biopharma Plc on January 26, 2024 and sell it today you would earn a total of 100.00 from holding Strongbridge Biopharma Plc or generate -100.0% return on investment over 90 days. Strongbridge Biopharma Plc is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Strongbridge, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Strongbridge Biopharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Strongbridge Biopharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Strongbridge Biopharma Plc, and traders can use it to determine the average amount a Strongbridge Biopharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SBBP |
Based on monthly moving average Strongbridge Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Strongbridge Biopharma by adding Strongbridge Biopharma to a well-diversified portfolio.
Strongbridge Biopharma Fundamentals Growth
Strongbridge Stock prices reflect investors' perceptions of the future prospects and financial health of Strongbridge Biopharma, and Strongbridge Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Strongbridge Stock performance.
| Return On Equity | -87.06 | |||
| Return On Asset | -27.5 | |||
| Profit Margin | (115.67) % | |||
| Operating Margin | (123.23) % | |||
| Current Valuation | 85.82 M | |||
| Shares Outstanding | 67.77 M | |||
| Price To Earning | 5.54 X | |||
| Price To Book | 2.42 X | |||
| Price To Sales | 3.90 X | |||
| Revenue | 34.72 M | |||
| EBITDA | (37.68 M) | |||
| Cash And Equivalents | 63.77 M | |||
| Cash Per Share | 0.94 X | |||
| Total Debt | 18.68 M | |||
| Debt To Equity | 0.42 % | |||
| Book Value Per Share | 0.83 X | |||
| Cash Flow From Operations | (33.98 M) | |||
| Earnings Per Share | (0.72) X | |||
| Total Asset | 97.33 M | |||
| Retained Earnings | (80.8 M) | |||
| Current Asset | 52.88 M | |||
| Current Liabilities | 5.48 M | |||
Things to note about Strongbridge Biopharma performance evaluation
Checking the ongoing alerts about Strongbridge Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Strongbridge Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Strongbridge Biopharma is not yet fully synchronised with the market data | |
| Strongbridge Biopharma has some characteristics of a very speculative penny stock | |
| Strongbridge Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 34.72 M. Net Loss for the year was (40.16 M) with profit before overhead, payroll, taxes, and interest of 28.52 M. | |
| Strongbridge Biopharma Plc currently holds about 63.77 M in cash with (33.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94. | |
| Roughly 67.0% of the company shares are owned by institutional investors |
- Analyzing Strongbridge Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Strongbridge Biopharma's stock is overvalued or undervalued compared to its peers.
- Examining Strongbridge Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Strongbridge Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Strongbridge Biopharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Strongbridge Biopharma's stock. These opinions can provide insight into Strongbridge Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Strongbridge Biopharma information on this page should be used as a complementary analysis to other Strongbridge Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Strongbridge Stock
If you are still planning to invest in Strongbridge Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Strongbridge Biopharma's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |